Human or veterinary use is prohibited under this research-use designation.The research-use-only designation means that scientists and institutions purchasing these compounds understand the legal and regulatory framework surrounding their use
GH can affect glucose FDA Status AOD-9604 Not approved (GRAS for the oral form) Tesamorelin FDA-approved (Egrifta, 2010) Human Evidence AOD-9604 Modest weight-loss results in trials Tesamorelin 2 Phase 3 RCTs, 816 patients Fat Targeted AOD-9604 General adipose, including abdominal Tesamorelin Visceral (deep belly) fat specifically Best-For AOD-9604 Fat support without shifting hormones Tesamorelin Deep visceral fat
Our clients know what they are getting with each session
Book your appointment today and take the first step towards better energy and well-being
Higher doses and more palatable formulations, such as sprays, are typically pricier
However, we prefer subcutaneous administration over intramuscular injection, especially for frequent self-injection